Skip to Main Content

Pharma Services Due Diligence: Identifying the Commercial Factors Impacting a Successful Private Equity Transaction

White Paper|

By Ryan Coe, Ph.D., Matt Haynes, Ph.D.

Maximizing return on invested capital (ROIC) for private equity-owned contract research, development, manufacturing, and services organizations (CXO) certainly requires strong business fundamentals – buy-side confidence in the underlying assets will make or break a transaction. Learn more.

Pharma Services Due Diligence: Identifying the Commercial Factors Impacting a Successful Private Equity Transaction

Please submit the form below to view this resource.

Request Access

Please fill out the form below to access our Industry Resources.

By submitting this form, you agree to our use of this information for the purpose of contacting you. For more information, please refer to our privacy policy.

Maximize value across the product and patient journeys. Find out how.